Brentuximab Intravenous and Von willebrand factor recombinant Intravenous
Determining the interaction of Brentuximab Intravenous and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brentuximab
Brand name: Adcetris
Synonyms: Brentuximab vedotin, Brentuximab Vedotin
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brentuximab Intravenous-Vonvendi
- Brentuximab Intravenous-Vopac
- Brentuximab Intravenous-Vopac MDS
- Brentuximab Intravenous-Vorapaxar
- Brentuximab Intravenous-Vorapaxar Sulfate
- Brentuximab Intravenous-Voraxaze
- Von willebrand factor recombinant Intravenous-Brentuximab vedotin
- Von willebrand factor recombinant Intravenous-Breo Ellipta
- Von willebrand factor recombinant Intravenous-Brethine
- Von willebrand factor recombinant Intravenous-Brethine Subcutaneous
- Von willebrand factor recombinant Intravenous-Bretylium
- Von willebrand factor recombinant Intravenous-Bretylium Injection